摘要
本文对103例膀胱肿瘤和121例泌尿系非肿瘤病人膀胱冲洗液进行了290次流式细胞分析(FCM)检测,前者FCM阳性者94例,FCM阳性率为91.3％;后者FCM阳性者6例,FCM假阳性率为5％。上述103例膀胱肿瘤病人在治疗前均做过尿细胞学检查和膀胱镜检查,尿细胞学检查阳性者42例,阳性率40.8％,膀胱镜检查发现肿瘤者96例,不能作出诊断者7例,其中6例FCM检测阳性。结果提示,FCM存诊断膀胱肿瘤方面明显优于尿细胞学检查,并在一定程度上,可与膀胱镜检查相互弥补存诊断膀胱肿瘤方面存在的不足。
Flow cytometry (FCM) was carried out on bladder irrigation specimens from 103 patients with urinary bladder cancer. In these 103 patients with bladder tumor, FCM was positive in 94 and negative in 9, a positive rate of 91.3%. Cystoscopic findings were positive in 96 patients and negative in 7. However, FCM was positive in the 6 patients with negative cystoscopy. Cytologic examination was positive in 42, with a positive rate of 40.8%. The results indicate that in the diagnosis of bladder tumor FCM was superior to cytology and to some extent FCM was supplementary to cystoscopy.
出处
《上海医学》
CAS
CSCD
北大核心
1990年第1期16-20,共5页
Shanghai Medical Journal
